Search research articles
Contact Us
Filters
Showing results (151-160 of 224) with videos related to
Page
of 23
Sort By:
World Neurosurgery
|
June 24, 2021
Unfractionated Heparin TID Dosing Regimen Is Associated With a Lower Rate of Pulmonary Embolism When Compared With BID Dosing in Patients Undergoing Craniotomy
Vineeth Thirunavu, Viswajit Kandula, Parth Shah, et al.
Biorxiv : the Preprint Server for Biology
|
February 24, 2023
High-gamma activity is coupled to low-gamma oscillations in precentral cortices and modulates with movement and speech
Jeffrey Z Nie, Robert D Flint, Prashanth Prakash, et al.
Eneuro
|
January 19, 2024
High-Gamma Activity Is Coupled to Low-Gamma Oscillations in Precentral Cortices and Modulates with Movement and Speech
Jeffrey Z Nie, Robert D Flint, Prashanth Prakash, et al.
Future Oncology (London, England)
|
January 9, 2025
Levetiracetam and valproic acid in glioma: antiseizure and potential antineoplastic effects
Bobak F Khalili, Tobias Walbert, Craig Horbinski, et al.
Journal of Neurosurgery
|
May 10, 2022
Impact of intraoperative direct cortical stimulation dynamics on perioperative seizures and afterdischarge frequency in patients undergoing awake craniotomy
Collin J Larkin, Ketan Yerneni, Constantine L Karras, et al.
Journal of Tissue Engineering and Regenerative Medicine
|
October 7, 2015
Mesenchymal stromal SB623 cell implantation mitigates nigrostriatal dopaminergic damage in a mouse model of Parkinson's disease
Ciara C Tate, Vivian P Chou, Carla Campos, et al.
Journal of the National Cancer Institute
|
March 20, 2003
Variations in lung cancer risk among smokers
Peter B Bach, Michael W Kattan, Mark D Thornquist, et al.
Cancer
|
November 14, 2017
Gross total resection and adjuvant radiotherapy most significant predictors of improved survival in patients with atypical meningioma
Nicholas R Rydzewski, Maciej S Lesniak, James P Chandler, et al.
Neuro-Oncology
|
April 18, 2025
The excitatory milieu in glioma: mechanisms and therapeutic avenues
Bobak F Khalili, Karan Dixit, David O Kamson, et al.
Targeted Oncology
|
June 8, 2017
A Phase 1 Study of LY2874455, an Oral Selective pan-FGFR Inhibitor, in Patients with Advanced Cancer
Michael Michael, Yung-Jue Bang, Young Suk Park, et al.
Page
of 23
Search research articles
Search
Showing results (151-160 of 224) with videos related to
Sort By:
Page
of 23
World Neurosurgery
|
June 24, 2021
Unfractionated Heparin TID Dosing Regimen Is Associated With a Lower Rate of Pulmonary Embolism When Compared With BID Dosing in Patients Undergoing Craniotomy
Vineeth Thirunavu, Viswajit Kandula, Parth Shah, et al.
Biorxiv : the Preprint Server for Biology
|
February 24, 2023
High-gamma activity is coupled to low-gamma oscillations in precentral cortices and modulates with movement and speech
Jeffrey Z Nie, Robert D Flint, Prashanth Prakash, et al.
Eneuro
|
January 19, 2024
High-Gamma Activity Is Coupled to Low-Gamma Oscillations in Precentral Cortices and Modulates with Movement and Speech
Jeffrey Z Nie, Robert D Flint, Prashanth Prakash, et al.
Future Oncology (London, England)
|
January 9, 2025
Levetiracetam and valproic acid in glioma: antiseizure and potential antineoplastic effects
Bobak F Khalili, Tobias Walbert, Craig Horbinski, et al.
Journal of Neurosurgery
|
May 10, 2022
Impact of intraoperative direct cortical stimulation dynamics on perioperative seizures and afterdischarge frequency in patients undergoing awake craniotomy
Collin J Larkin, Ketan Yerneni, Constantine L Karras, et al.
Journal of Tissue Engineering and Regenerative Medicine
|
October 7, 2015
Mesenchymal stromal SB623 cell implantation mitigates nigrostriatal dopaminergic damage in a mouse model of Parkinson's disease
Ciara C Tate, Vivian P Chou, Carla Campos, et al.
Journal of the National Cancer Institute
|
March 20, 2003
Variations in lung cancer risk among smokers
Peter B Bach, Michael W Kattan, Mark D Thornquist, et al.
Cancer
|
November 14, 2017
Gross total resection and adjuvant radiotherapy most significant predictors of improved survival in patients with atypical meningioma
Nicholas R Rydzewski, Maciej S Lesniak, James P Chandler, et al.
Neuro-Oncology
|
April 18, 2025
The excitatory milieu in glioma: mechanisms and therapeutic avenues
Bobak F Khalili, Karan Dixit, David O Kamson, et al.
Targeted Oncology
|
June 8, 2017
A Phase 1 Study of LY2874455, an Oral Selective pan-FGFR Inhibitor, in Patients with Advanced Cancer
Michael Michael, Yung-Jue Bang, Young Suk Park, et al.
Page
of 23